Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Feb 6;2(2):CD012608.
doi: 10.1002/14651858.CD012608.pub3.

Modified dietary fat intake for treatment of gallstone disease in people of any age

Angela M Madden  1 , Nigel C Smeeton  2 , Alison Culkin  3 , Daksha Trivedi  2
Affiliations
Meta-Analysis

Modified dietary fat intake for treatment of gallstone disease in people of any age

Angela M Madden et al. Cochrane Database Syst Rev. .

Abstract

Background: The prevalence of gallstones varies between less than 1% and 64% in different populations and is thought to be increasing in response to changes in nutritional intake and increasing obesity. Some people with gallstones have no symptoms but approximately 2% to 4% develop them each year, predominantly including severe abdominal pain. People who experience symptoms have a greater risk of developing complications. The main treatment for symptomatic gallstones is cholecystectomy. Traditionally, a low-fat diet has also been advised to manage gallstone symptoms, but there is uncertainty over the evidence to support this.

Objectives: To evaluate the benefits and harms of modified dietary fat intake in the treatment of gallstone disease in people of any age.

Search methods: We searched the Cochrane Hepato-Biliary Group Controlled Trials Register, the Cochrane Central Register of Controlled Trials in the Cochrane Library, MEDLINE ALL Ovid, Embase Ovid, and three other databases to 17 February 2023 to identify randomised clinical trials in people with gallstones. We also searched online trial registries and pharmaceutical company sources, for ongoing or unpublished trials to March 2023.

Selection criteria: We included randomised clinical trials (irrespective of language, blinding, or status) in people with gallstones diagnosed using ultrasonography or conclusive imaging methods. We excluded participants diagnosed with another condition that may compromise dietary fat tolerance. We excluded trials where data from participants with gallstones were not reported separately from data from participants who did not have gallstones. We included trials that investigated other interventions (e.g. trials of drugs or other dietary (non-fat) components) providing that the trial groups had received the same proportion of drug or other dietary (non-fat) components in the intervention.

Data collection and analysis: We intended to undertake meta-analysis and present the findings according to Cochrane recommendations. However, as we identified only five trials, with data unsuitable and insufficient for analyses, we described the data narratively.

Main results: We included five trials but only one randomised clinical trial (69 adults), published in 1986, reported outcomes of interest to the review. The trial had four dietary intervention groups, three of which were relevant to this review. We assessed the trial at high risk of bias. The dietary fat modifications included a modified cholesterol intake and medium-chain triglyceride supplementation. The control treatment was a standard diet. The trial did not report on any of the primary outcomes in this review (i.e. all-cause mortality, serious adverse events, and health-related quality of life). The trial reported on gallstone dissolution, one of our secondary outcomes. We were unable to apply the GRADE approach to determine certainty of evidence because the included trial did not provide data that could be used to generate an estimate of the effect on this or any other outcome. The trial expressed its finding as "no significant effect of a low-cholesterol diet in the presence of ursodeoxycholic acid on gallstone dissolution." There were no serious adverse events reported. The included trial reported that they received no funding that could bias the trial results through conflicts of interest. We found no ongoing trials.

Authors' conclusions: The evidence about the effects of modifying dietary fat on gallstone disease versus standard diet is scant. We lack results from high-quality randomised clinical trials which investigate the effects of modification of dietary fat and other nutrient intakes with adequate follow-up. There is a need for well-designed trials that should include important clinical outcomes such as mortality, quality of life, impact on dissolution of gallstones, hospital admissions, surgical intervention, and adverse events.

PubMed Disclaimer

Conflict of interest statement

AMM: none.

NS: none.

AC: none.

DT is an editor with the Cochrane Injuries Group.

Figures

1
1
Study flow diagram (Page 2021a; Page 2021b). Date of search 17 February 2023.
2
2
Risk of bias summary: review authors' judgements about each risk of bias item for the included study that reported a secondary outcome of the systematic review (Lefkof 1986).
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Burnand 2016 {published and unpublished data}61630192
    1. Burnand KM, Lahiri RP, Burr N, Jansen van Rensburg L, Lewis MP. A randomised, single blinded trial, assessing the effect of a two week preoperative very low calorie diet on laparoscopic cholecystectomy in obese patients. HPB 2016;18(5):456-61. [DOI: 10.1016/j.hpb.2016.01.545] - DOI - PMC - PubMed
Lee 1985 {published data only (unpublished sought but not used)}
    1. Lee DW, Gilmore CJ, Bonorris G, Cohen H, Marks JW, Cho-Sue M, et al. Effect of dietary cholesterol on biliary lipids in patients with gallstones and normal subjects. American Journal of Clinical Nutrition 1985;42(3):414-20. [DOI: 10.1093/ajcn/42.3.414] - DOI - PubMed
Lefkof 1986 {published data only (unpublished sought but not used)}
    1. Frenkiel PG, Lee DW, Cohen H, Gilmore CJ, Resser K, Bonorris GG, et al. The effect of diet on bile acid kinetics and biliary lipid secretion in gallstone patients treated with ursodeoxycholic acid. American Journal of Clinical Nutrition 1986;43(2):239-50. [DOI: 10.1093/ajcn/43.2.239] - DOI - PubMed
    1. Lefkof IR, Frenkiel PG, Lee DW, Cohen H, Bonorris GG, Gilmore CJ, et al. Effect of diet on dissolution of gallstones by ursodeoxycholic acid, including a comparison between ultrasonography and cholecystography. Mount Sinai Journal of Medicine 1986;53(4):241-9. [PMID: ] - PubMed
Maudgal 1978 {published data only (unpublished sought but not used)}
    1. Maudgal DP, Bird R, Blackwood WS, Northfield TC. Low-cholesterol diet: enhancement of effect of CDCA in patients with gall stones. British Medical Journal 1978;2(6141):851-3. [DOI: 10.1136/bmj.2.6141.851] - DOI - PMC - PubMed
Maudgal 1982 {published data only (unpublished sought but not used)}
    1. Maudgal DP, Kupfer RM, Northfield TC. Minimum effective dose of chenic acid for gallstone patients: reduction with bedtime administration and low cholesterol diet. Gut 1982;23(4):280-4. [DOI: 10.1136/gut.23.4.280] - DOI - PMC - PubMed

References to studies excluded from this review

Burr 2014 {published data only}
    1. Burr N, Burnand K, Lahiri R, Bennett JM, Lewis MP. A randomised, single-blinded trial assessing the effect of a two week preoperative very low calorie diet on laparoscopic cholecystectomy procedure in obese patients. Gastroenterology 2014;146(5 Suppl 1):S-1024. [DOI: 10.1016/S0016-5085(14)63732-X] - DOI - PMC - PubMed
ChiCTR1900021184 {unpublished data only}
    1. ChiCTR1900021184. A randomized controlled trial for ursodeoxycholic acid in preventing gallstone recurrence. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR1900021184 (first received 1 February 2019).
de Menezes 2013 {published data only}
    1. Menezes HL, Fireman PA, Wanderley VE, Menconça AM, Bispo RK, Reis MR. Randomized study for assessment of hypolipidic diet in digestive symptoms immediately following laparoscopic cholecystectomy. Revista do Colegio Brasileiro de Cirurgioes 2013;40(3):203-7. [DOI: 10.1590/s0100-69912013000300007] - DOI - PubMed
Gebhard 1996 {published data only}
    1. Gebhard RL, Prigge WF, Ansel HJ, Schlasner L, Ketover SR, Sande D, et al. The role of gallbladder emptying in gallstone formation during diet-induced rapid weight loss. Hepatology 1996;24(3):544-8. [DOI: 10.1002/hep.510240313] - DOI - PubMed
Grundy 1987 {published data only}
    1. Grundy SM, Kalser SC. Highlights of the meeting on prevention of gallstones. Hepatology 1987;7(5):946-51. [DOI: 10.1002/hep.1840070526] - DOI - PubMed
Kern 1994 {published data only}
    1. Kern F Jr. Effects of dietary cholesterol on cholesterol and bile acid homeostasis in patients with cholesterol gallstones. Journal of Clinical Investigation 1994;93(3):1186-94. [DOI: 10.1172/JCI117072] - DOI - PMC - PubMed
Kupfer 1982 {published data only}
    1. Kupfer RM, Maudgal DP, Northfield TC. Gallstone dissolution rate during chenic acid therapy. Effect of bedtime administration plus low cholesterol diet. Digestive Diseases and Sciences 1982;27(11):1025-9. [DOI: 10.1007/BF01391750] - DOI - PubMed
Kurbanov 2003 {published data only}
    1. Kurbanov SK. Optimization of diet therapy in patients with gallstones complicated with obesity and impaired glucose tolerance [Ob optimizatsii dietoterapii bol'nykh zhelchnokamennoĭ bolezn'iu s soputstvuiushchim ozhireniem i narusheniem tolerantnosti k gliukoze]. Voprosy Pitaniia 2003;72(5):22-4. [PMID: ] - PubMed
Lean 2018 {published data only}
    1. Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 2018;391(10120):541-51. [DOI: 10.1016/S0140-6736(17)33102-1] - DOI - PubMed
Mogadam 1984 {published data only}
    1. Mogadam M, Albarelli J, Ahmed SW, Grogan EJ, Mascatello VJ. Gallbladder dynamics in response to various meals: is dietary fat restriction necessary in the management of gallstones? American Journal of Gastroenterology 1984;79(10):745-7. [PMID: ] - PubMed
Rumessen 2005 {published data only}
    1. Rumessen JJ. Gastrointestinal function following cholecystectomy [Mave-tarm-funktion efter kolecystektomi]. Ugeskrift for Laeger 2005;167(24):2623-4. [PMID: ] - PubMed
Stokes 2014a {published data only}
    1. Stokes CS, Gluud LL, Casper M, Lammert F. Primary prevention of gallbladder stones during weight loss: systematic review and meta-analysis of randomised controlled trials. Journal of Hepatology 2014;60(Suppl 1):S182. - PubMed
Stokes 2014b {published data only}
    1. Stokes CS, Gluud LL, Casper M, Lammert F. Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials. Clinical Gastroenterology and Hepatology 2014;12(7):1090-100. [DOI: 10.1016/j.cgh.2013.11.031] - DOI - PubMed
Yago 2005 {published data only}
    1. Yago MD, González V, Serrano P, Calpena R, Martínez MA, Martínez-Victoria E, et al. Effect of the type of dietary fat on biliary lipid composition and bile lithogenicity in humans with cholesterol gallstone disease. Nutrition 2005;21(3):339-47. [DOI: 10.1016/j.nut.2004.06.028] - DOI - PubMed

Additional references

AHA Nutrition Committee 2006
    1. American Heart Association Nutrition Committee, Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006;114(1):82-96. [DOI: 10.1161/CIRCULATIONAHA.106.176158] - DOI - PubMed
Aune 2016
    1. Aune D, Vatten LJ. Diabetes mellitus and the risk of gallbladder disease: a systematic review and meta-analysis of prospective studies. Journal of Diabetes and its Complications 2016;30(2):368-73. - PubMed
Behar 1989
    1. Behar J, Lee KY, Thompson WR, Biancani P. Gallbladder contraction in patients with pigment and cholesterol stones. Gastroenterology 1989;97(6):1479-84. [PMID: ] - PubMed
Berger 2015
    1. Berger S, Raman G, Vishwanathan R, Jacques PF, Johnson EJ. Dietary cholesterol and cardiovascular disease: a systematic review and meta-analysis. American Journal of Clinical Nutrition 2015;102(2):276-94. [DOI: 10.3945/ajcn.114.100305] - DOI - PubMed
Bjelakovic 2021
    1. Bjelakovic M, Nikolova D, Bjelakovic G, Gluud C. Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database of Systematic Reviews 2021, Issue 8. Art. No: CD011564. [DOI: 10.1002/14651858.CD011564.pub3] - DOI - PMC - PubMed
Borenstein 2013
    1. Borenstein M, Higgins JP. Meta-analysis and subgroups. Prevention Science 2013;14:134-43. [DOI: 10.1007/s11121-013-0377-7] - DOI - PubMed
Brazzelli 2014
    1. Brazzelli M, Cruickshank M, Kilonzo M, Ahmed I, Stewart F, McNamee P, et al. Clinical effectiveness and cost-effectiveness of cholecystectomy compared with observation/conservative management for preventing recurrent symptoms and complications in adults presenting with uncomplicated symptomatic gallstones or cholecystitis: a systematic review and economic evaluation. Health Technology Assessment 2014;18(55):1-101. - PMC - PubMed
British Liver Trust 2018
    1. British Liver Trust. Gallstones. britishlivertrust.org.uk/wp-content/uploads/Gallstones-web-version.pdf (accessed 25 October 2023).
Brok 2008
    1. Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. Journal of Clinical Epidemiology 2008;61(8):763-9. [PMID: ] - PubMed
Brok 2009
    1. Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta-analyses may be inconclusive — trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. International Journal of Epidemiology 2009;38(1):287-98. - PubMed
Buzzetti 2021
    1. Buzzetti E, Linden A, Best LM, Madden AM, Roberts D, Chase TJ, et al. Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2021, Issue 6. Art. No: CD013156. [DOI: 10.1002/14651858.CD013156.pub2] - DOI - PMC - PubMed
Campbell 2020
    1. Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ (Clinical Research Ed.) 2020;368:l6890. [DOI: 10.1136/bmj.l6890] - DOI - PMC - PubMed
Colvin 2022
    1. Colvin HS, Kimura T, Iso H, Ikehara S, Sawada N, Tsugane S. Risk Factors for gallstones and cholecystectomy: a large-scale population-based prospective cohort study in Japan. Digestive Diseases 2022;40(3):385-93. - PubMed
Covidence [Computer program]
    1. Covidence systematic review software. Melbourne, Australia: Veritas Health Innovation, (accessed 5 June 2023). www.covidence.org.
Deeks 2021
    1. Deeks JJ, Higgins JP, Altman DG, editor(s). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.
DerSimonian 1986
    1. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88. - PubMed
Di Ciaula 2013
    1. Di Ciaula A, Wang DQ, Bonfrate L, Portincasa P. Current views on genetics and epigenetics of cholesterol gallstone disease. Cholesterol 2013;2013:298421. [DOI: 10.1155/2013/298421] - DOI - PMC - PubMed
Dupont 2022
    1. Dupont B, Dejardin O, Bouvier V, Piquet MA, Alves A. Systematic review: impact of social determinants of health on the management and prognosis of gallstone disease. Health Equity 2022;6(1):819-35. [DOI: 10.1089/heq.2022.0063] - DOI - PMC - PubMed
EASL 2016
    1. European Association for the Study of Liver Disease (EASL). EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones. Journal of Hepatology 2016;65(1):146-81. - PubMed
Eldridge 2021
    1. Eldridge S, Campbell MK, Campbell MJ, Drahota AK, Giraudeau B, Reeves BC, et al. Revised Cochrane risk of bias tool for randomized trials (RoB 2). Additional considerations for cluster-randomized trials (RoB 2 CRT). www.riskofbias.info/welcome/rob-2-0-tool/rob-2-for-cluster-randomized-tr... (accessed 22 May 2023).
EuroQol Group 1990
    1. EuroQol Group. EuroQol — a new facility for the measurement of health-related quality of life. Health Policy 1990;16(3):199-208. [DOI: 10.1016/0168-8510(90)90421-9] - DOI - PubMed
Festi 1998
    1. Festi D, Colecchia A, Orsini M, Sangermano A, Sottili S, Simoni P, et al. Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well). International Journal of Obesity and Related Metabolic Disorders 1998;22(6):592-600. - PubMed
Festi 2000
    1. Festi D, Colecchia A, Larocca A, Villanova N, Mazzella G, Petroni ML, et al. Review: low caloric intake and gall-bladder motor function. Alimentary Pharmacology & Therapeutics 2000;14(Suppl 2):51-3. [PMID: ] - PubMed
Festi 2010
    1. Festi D, Reggiani ML, Attili AF, Loria P, Pazzi P, Scaioli E, et al. Natural history of gallstone disease: expectant management or active treatment? Results from a population-based cohort study. Journal of Gastroenterology and Hepatology 2010;25(4):719-24. [DOI: 10.1111/j.1440-1746.2009.06146.x] - DOI - PubMed
Ganji 1994
    1. Ganji V, Kies CV. Psyllium husk fibre supplementation to soybean and coconut oil diets of humans: effect on fat digestibility and faecal fatty acid excretion. European Journal of Clinical Nutrition 1994;48(8):595-7. - PubMed
Garratt 1993
    1. Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ (Clinical Research Ed.) 1993;306(6890):1440-4. [DOI: 10.1136/bmj.306.6890.1440] - DOI - PMC - PubMed
Goldman 2020
    1. Goldman DA. Gallbladder, gallstones, and diseases of the gallbladder in children. Pediatrics in Review 2020;41(12):623-9. [DOI: 10.1542/pir.2019-0077] - DOI - PubMed
Gonzalez‐Hita 2014
    1. Gonzalez-Hita M, Batis-Ruvalcaba C, Sanchez-Enriquez S. Diet and nutritional factors related to symptomatic gallstone disease in women. Journal of Clinical Case Reports 2014;4(12):1-6.
GRADEpro GDT [Computer program]
    1. GRADEpro GDT. Version accessed 4 November 2020. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. Available at gradepro.org.
Gurusamy 2014
    1. Gurusamy K, Davidson BR. Gallstones. BMJ (Clinical Research Ed.) 2014;348:g2669. [DOI: 10.1136/bmj.g2669] - DOI - PubMed
Healthline 2018
    1. Healthline. Gallbladder diet. www.healthline.com/health/gallbladder-diet (accessed 22 May 2023).
Higgins 2002
    1. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58. - PubMed
Higgins 2003
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clinical Research Ed.) 2003;327(7414):557-60. - PMC - PubMed
Higgins 2021a
    1. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.
Higgins 2021b
    1. Higgins JP, Eldridge S, Li T, editor(s). Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.
Higgins 2021c
    1. Higgins JP, Savović J, Page MJ, Elbers RG, Sterne JA. Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.
Higgins 2021d
    1. Higgins JP, Lasserson T, Chandler J, Tovey D, Thomas J, Flemyng E, et al. Methodological Expectations of Cochrane Intervention Reviews. community.cochrane.org/mecir-manual (accessed 22 May 2023).
Higgins 2023
    1. Higgins JP, Li T, Deeks JJ, editor(s). Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023. Available from www.training.cochrane.org/handbook.
Hopman 1985
    1. Hopman WP, Jansen JB, Lamers CB. Comparative study of the effects of equal amounts of fat, protein, and starch on plasma cholecystokinin in man. Scandinavian Journal of Gastroenterology 1985;20(7):843-7. [PMID: ] - PubMed
Hopman 1987
    1. Hopman WP, Jansen JB, Rosenbusch G, Lamers CB. Cephalic stimulation of gallbladder contraction in humans: role of cholecystokinin and the cholinergic system. Digestion 1987;38(4):197-203. [PMID: ] - PubMed
Hörnell 2017
    1. Hörnell A, Berg C, Forsum E, Larsson C, Sonestedt E, Åkesson A, et al. Perspective: an extension of the STROBE statement for observational studies in nutritional epidemiology (STROBE-nut): explanation and elaboration. Advances in Nutrition 2017;8(5):652-78. [DOI: 10.3945/an.117.015941] - DOI - PMC - PubMed
ICH‐GCP 2016
    1. International Council for Harmonisation of technical requirements for pharmaceuticals for human use (ICH). ICH Harmonised Guideline. Integrated addendum to ICH E6(R1): guideline for good clinical practice E6(R2). database.ich.org/sites/default/files/E6_R2_Addendum.pdf (accessed 5 June 2023).
Jakobsen 2014
    1. Jakobsen J, Wetterslev J, Winkel P, Lange T, Gluud C. Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BMC Medical Research Methodology 2014;14:120. - PMC - PubMed
Jakobsen 2017
    1. Jakobsen JC, Gluud C, Wetterslev J, Winkel P. When and how should multiple imputation be used for handling missing data in randomized clinical trials – a practical guide with flowcharts. BMC Medical Research Methodology 2017;17(1):162. [DOI: 10.1186/s12874-017-0442-1] - DOI - PMC - PubMed
Jones 2023a
    1. Jones MW, Weir CB, Ghassemzadeh S. Gallstones (cholelithiasis). In: www.statpearls.com/ArticleLibrary/viewarticle/22041. Tampa, Florida: StatPearls [Internet], (accessed 6 November 2023).
Jones 2023b
    1. Jones MW, Guay E, Deppen JG. Open cholecystectomy. In: www.statpearls.com/point-of-care/38103. (accessed 6 November 2023).
Keus 2006
    1. Keus F, Jong JA, Gooszen HG. Laparoscopic versus open cholecystectomy for patients with symptomatic cholecystolithiasis. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No: CD006231. [DOI: 10.1002/14651858.CD006231] - DOI - PubMed
Kiani 2020
    1. Kiani Q, Farooqui F, Khan MS, Khan AZ, Nauman Tariq M, Akhtar A. Association of body mass index and diet with symptomatic gall stone disease: a case-control study. Cureus 2020;12(3):e7188. - PMC - PubMed
Kjaergard 2001
    1. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-9. - PubMed
Latif 2023
    1. Latif EA, Inamullah, Mahdi H, Zarour A, Aftab Z, Aboumarzouk OM. Is percutaneous extraction of gallstones safe and effective in high-risk patients? Evidence from a systematic review. Surgeon 2023;21(2):99-107. - PubMed
Lecerf 2011
    1. Lecerf JM, Lorgeril M. Dietary cholesterol: from physiology to cardiovascular risk. British Journal of Nutrition 2011;106(1):6-14. - PubMed
Lechat 2016
    1. Lachat C, Hawwash D, Ocké MC, Berg C, Forsum E, Hörnell A, et al. Strengthening the reporting of observational studies in epidemiology-nutritional epidemiology (STROBE-nut): an extension of the STROBE statement. PLOS Medicine 2016;13(6):e1002036. [DOI: 10.1371/journal.pmed] - DOI - PMC - PubMed
Madden 1992
    1. Madden A. The role of low fat diets in the management of gall-bladder disease. Journal of Human Nutrition and Dietetics 1992;5:267-73. [DOI: 10.1111/j.1365-277X.1992.tb00165.x] - DOI
Markotic 2020
    1. Markotic F, Grgic S, Poropat G, Fox A, Nikolova D, Vukojevic K, et al. Antibiotics for adults with acute cholecystitis or acute cholangitis or both. Cochrane Database of Systematic Reviews 2020, Issue 6. Art. No: CD013646. [DOI: 10.1002/14651858.CD013646] - DOI
McKenzie 2021
    1. McKenzie JE, Brennan SE. Chapter 12: Synthesizing and presenting findings using other methods. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.
Meader 2014
    1. Meader N, King K, Llewellyn A, Norman G, Brown J, Rodgers M, et al. A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation. Systematic Reviews 2014;3(82):1-9. - PMC - PubMed
Mendez‐Sanchez 2007
    1. Mendez-Sanchez N, Zamora-Valdes D, Chavez-Tapia NC, Uribe M. Role of diet in cholesterol gallstone formation. Clinica Chimica Acta 2007;376(1-2):1-8. [PMID: ] - PubMed
Misciagna 1999
    1. Misciagna G, Centonze S, Leoci C, Guerra V, Cisternino AM, Ceo R, et al. Diet, physical activity, and gallstones – a population-based, case-control study in southern Italy. American Journal of Clinical Nutrition 1999;69(1):120-6. - PubMed
Mogadam 1984
    1. Mogadam M, Albarelli J, Ahmed SW, Grogan EJ, Mascatello VJ. Gallbladder dynamics in response to various meals: is dietary fat restriction necessary in the management of gallstones? American Journal of Gastroenterology 1984;79(10):745-7. [PMID: ] - PubMed
Moher 2009
    1. Moher D, Liberati A, TetzlaI J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Medicine 2009;6(7):e1000097. [DOI: 10.1371/journal.pmed.1000097] - DOI - PMC - PubMed
MyHealth.Alberta.ca 2022
    1. MyHealthAlbertaca. Gallstones. myhealth.alberta.ca/Health/Pages/conditions.aspx?hwid=hw107151 (accessed 25 October 2023).
Naing 2020
    1. Naing C, Leong C-O, Aung HH, Mai C-W, Chan EW, Kew ST. Gene therapy for people with hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2020, Issue 9. Art. No: CD013731. [DOI: 10.1002/14651858.CD013731] - DOI - PMC - PubMed
NICE 2014
    1. National Institute of Health and Care Excellence. Gallstone disease: diagnosis and management of cholelithiasis, cholecystitis and choledocholithiasis, 2014. www.nice.org.uk/guidance/cg188/evidence/full-guideline-193302253 (accessed 5 June 2023). - PubMed
Nyström 2002
    1. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordensjöld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002;359:909-19. [DOI: 10.1016/S0140-6736(02)08020-0] - DOI - PubMed
Page 2021a
    1. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Research Ed.) 2021;372:n71. - PMC - PubMed
Page 2021b
    1. Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ (Clinical Research Ed.) 2021;372:n160. - PMC - PubMed
Patient 2020
    1. Patient. Gallstones diet sheet. patient.info/news-and-features/gallstones-diet-sheet (accessed 22 May 2023).
Pearson 2021
    1. Pearson GJ, Thanassoulis G, Anderson TJ, Barry AR, Couture P, Dayan N, et al. 2021 Canadian Cardiovascular Society Guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults. Canadian Journal of Cardiology 2021;37(8):1129-50. [DOI: 10.1016/j.cjca.2021.03.016] - DOI - PubMed
Review Manager 2020 [Computer program]
    1. Review Manager (RevMan). Version 6.5.1. The Cochrane Collaboration, 2023. Available at revman.cochrane.org.
Savović 2012a
    1. Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies. Health Technology Assessment 2012;16(35):1-82. - PubMed
Savović 2012b
    1. Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomized controlled trials. Annals of Internal Medicine 2012;157(6):429-38. - PubMed
Savović 2018
    1. Savović J, Turner RM, Mawdsley D, Jones H, Beynon R, Higgins JP, et al. Association of between risk-of-bias assessments and results of randomized trials in Cochrane reviews. The ROBES meta-epidemiologic study. American Journal of Epidemiology 2018;187(5):1113-22. - PMC - PubMed
Sawata 2011
    1. Sawata H, Tsutani K. How can the evidence from global large-scale clinical trials for cardiovascular diseases be improved? BMC Research Notes 2011;4:222. - PMC - PubMed
Schroor 2019
    1. Schroor MM, Sennels HP, Fahrenkrug J, Jørgensen HL, Plat J, Mensink RP. Diurnal variation of markers for cholesterol synthesis, cholesterol absorption, and bile acid synthesis: a systematic review and the Bispebjerg study of diurnal variations. Nutrients 2019;11(7):1439. [DOI: 10.3390/nu11071439] - DOI - PMC - PubMed
Schulz 1995
    1. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association 1995;273(5):408-12. - PubMed
Schulz 2010
    1. Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ (Clinical Research Ed.) 2010;340:c332. - PMC - PubMed
Schünemann 2013
    1. Schünemann H, Brożek J, Guyatt G, Oxman A, editor(s). GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. The GRADE Working Group; 2013. Available from guidelinedevelopment.org/handbook (accessed 6 November 2023).
Sharma 2017
    1. Sharma A, Sharma KL, Gupta A, Yadav A, Kumar A. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: recent update. World Journal of Gastroenterology 2017;23(22):3978-98. [DOI: 10.3748/wjg.v23.i22.3978] [PMID: ] - DOI - PMC - PubMed
Staffa 2020
    1. Staffa SJ, Zurakowski D. Calculation of confidence intervals for differences in medians between groups and comparison of methods. Anesthesia and Analgesia 2020;130(2):542-6. - PubMed
Sterne 2001
    1. Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ (Clinical Research Ed.) 2001;323(7304):101-5. [DOI: 10.1136/bmj.323.7304.101] - DOI - PMC - PubMed
Sterne 2019
    1. Sterne JA, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ (Clinical Research Ed.) 2019;366:l4898. [DOI: 10.1136/bmj.l4898] - DOI - PubMed
Stinton 2010
    1. Stinton LM, Myers RP, Shaffer EA. Epidemiology of gallstones. Gastroenterology Clinics of North America 2010;39(2):157-69, vii. [PMID: ] - PubMed
Stokes 2014
    1. Stokes CS, Gluud LL, Casper M, Lammert F. Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials. Clinical Gastroenterology and Hepatology 2014;12(7):1090-100. - PubMed
Theuwissen 2008
    1. Theuwissen E, Mensink RP. Water-soluble dietary fibers and cardiovascular disease. Physiology & Behavior 2008;94(2):285-92. - PubMed
Thorlund 2009
    1. Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? International Journal of Epidemiology 2009;38(1):276-86. - PubMed
Thorlund 2017
    1. Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, Gluud C. User Manual for Trial Sequential Analysis (TSA); 2nd edition. Copenhagen Trial Unit, 2017. Available from ctu.dk/tsa/learn-more (accessed 5 June 2023).
Unalp‐Arida 2023
    1. Unalp-Arida A, Ruhl CE. Increasing gallstone disease prevalence and associations with gallbladder and biliary tract mortality in the US. Hepatology 2023;77(6):1882-95. - PubMed
Walker 2020
    1. Walker KF, Chappell LC, Hague WM, Middleton P, Thornton JG. Pharmacological interventions for treating intrahepatic cholestasis of pregnancy. Cochrane Database of Systematic Reviews 2020;7:1-123. [DOI: 10.1002/14651858.CD000493.pub3] - DOI - PMC - PubMed
Wetterslev 2008
    1. Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology 2008;61:64-75. [PMID: ] - PubMed
Wetterslev 2009
    1. Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Medical Research Methodology 2009;9:86. [PMID: ] - PMC - PubMed
Wetterslev 2017
    1. Wetterslev J, Jakobsen JC, Gluud C. Trial Sequential Analysis in systematic reviews with meta-analysis. BMC Medical Research Methodology 2017;17(1):39. [PMID: ] - PMC - PubMed
Wood 2008
    1. Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (Clinical Research Ed.) 2008;336:601-5. - PMC - PubMed

References to other published versions of this review

Madden 2017
    1. Madden AM, Trivedi D, Smeeton NC, Culkin A. Modified dietary fat intake for treatment of gallstone disease. Cochrane Database of Systematic Reviews 2017, Issue 3. Art. No: CD012608. [DOI: 10.1002/14651858.CD012608] - DOI - PMC - PubMed
Madden 2021
    1. Madden AM, Trivedi D, Smeeton NC, Culkin A. Modified dietary fat intake for treatment of gallstone disease. Cochrane Database of Systematic Reviews 2021, Issue 6. Art. No: CD012608. [DOI: 10.1002/14651858.CD012608.pub2] - DOI - PMC - PubMed

LinkOut - more resources